Paper2436751
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
Mirski SE and 2 others. Cancer Res, 1987. Cited by 345 papers, by iCite.
Cite this record
ConductScience Library. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Papers, record 2436751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2436751
- Cell line
- NCI-H69AR10 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Source Cell lines
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Small Cell | Major topic |
| Doxorubicin | Major topic |
| Lung Neoplasms | Major topic |
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | |
| Animals | |
| Antibodies, Monoclonal | |
| Cell Line | |
| Colchicine | |
| Daunorubicin | |
| Drug Resistance | |
| Enzyme-Linked Immunosorbent Assay | |
| Epirubicin | |
| Etoposide | |
| Glycoproteins | |
| Gramicidin | |
| Humans | |
| Immunosorbent Techniques | |
| Isoxazoles | |
| Menogaril | |
| Mice | |
| Mice, Inbred BALB C | |
| Mitoxantrone | |
| Nogalamycin | |
| Phenotype | |
| Vinblastine | |
| Vincristine |
Source PubMed
Cited by109
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 345 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41548807 | Loss of Payload Sensitivity and Other Mechanisms of Resistance to T-DXd in HER2-Mutant NSCLC: Implications for Subsequent Responsiveness to HER2 TKIs. | J Thorac Oncol | 2026 | https://conductscience.org/library/papers/41548807 | PubMed |
| 41129225 | Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancer. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/41129225 | PubMed |
| 41115858 | Leveraging platinum-protein interactions to overcome chemoresistance. | Nat Commun | 2025 | https://conductscience.org/library/papers/41115858 | PubMed |
| 41030978 | Lamin A/C Deficiency Drives Genomic Instability and Poor Survival in Small-Cell Lung Cancer through Increased R-loop Accumulation. | bioRxiv | 2025 | https://conductscience.org/library/papers/41030978 | PubMed |
| 40723843 | Predictive and Prognostic Relevance of ABC Transporters for Resistance to Anthracycline Derivatives. | Biomolecules | 2025 | https://conductscience.org/library/papers/40723843 | PubMed |
| 40705154 | Identification of key targets and exploration of therapeutic molecular mechanisms of natural compound tangeretin in osteosarcoma. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40705154 | PubMed |
| 40573290 | Multidrug Resistance: Are We Still Afraid of the Big Bad Wolf. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40573290 | PubMed |
| 40489532 | Thionated levofloxacin derivative: Potential repurposing for cancer treatment and synergism with doxorubicin on doxorubicin-resistant lung cancer cells. | PLoS One | 2025 | https://conductscience.org/library/papers/40489532 | PubMed |
| 40440076 | Molecular basis and therapeutic implications of binary YAPOn/YAPOff cancer classes. | Biochem J | 2025 | https://conductscience.org/library/papers/40440076 | PubMed |
| 40034926 | Role of Notch1 Signaling Pathway in Small Cell Lung Carcinoma. | Iran J Pathol | 2024 | https://conductscience.org/library/papers/40034926 | PubMed |
| 39982595 | The impact of the ATP-binding cassette (ABC) transporter family on multidrug resistance in head and neck tumors. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/39982595 | PubMed |
| 39444179 | Antiproliferative Activity of Cephalotaxus Esters: Overcoming Chemoresistance. | Comb Chem High Throughput Screen | 2025 | https://conductscience.org/library/papers/39444179 | PubMed |
| 39177280 | Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer. | Cancer Res Commun | 2024 | https://conductscience.org/library/papers/39177280 | PubMed |
| 38045829 | Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. | MedComm (2020) | 2023 | https://conductscience.org/library/papers/38045829 | PubMed |
| 38019857 | Adaptive DNA amplification of synthetic gene circuit opens a way to overcome cancer chemoresistance. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/38019857 | PubMed |
| 37989124 | Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers. | Radiat Res | 2024 | https://conductscience.org/library/papers/37989124 | PubMed |
| 37313175 | LRRC8A promotes the initial development of oxaliplatin resistance in colon cancer cells. | Heliyon | 2023 | https://conductscience.org/library/papers/37313175 | PubMed |
| 36562354 | Landscape of circular RNAs in different types of lung cancer and an emerging role in therapeutic resistance (Review). | Int J Oncol | 2023 | https://conductscience.org/library/papers/36562354 | PubMed |
| 36015341 | Identification of Transferrin Receptor 1 (TfR1) Overexpressed in Lung Cancer Cells, and Internalization of Magnetic Au-CoFe2O4 Core-Shell Nanoparticles Functionalized with Its Ligand in a Cellular Model of Small Cell Lung Cancer (SCLC). | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36015341 | PubMed |
| 35821751 | Pulmonary Neuroendocrine Cells and Small Cell Lung Carcinoma: Immunohistochemical Study Focusing on Mechanisms of Neuroendocrine Differentiation. | Acta Histochem Cytochem | 2022 | https://conductscience.org/library/papers/35821751 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2436751
GET https://conductscience.org/api/papers/v1/2436751/cited_by?page=2